Table of Contents
ISRN Cardiology
Volume 2012 (2012), Article ID 972341, 7 pages
http://dx.doi.org/10.5402/2012/972341
Clinical Study

Changes in Lipids and Lipoprotein Indices in Relation to the Severity of Hypertension in Newly Diagnosed Hypertensive Nigerians

1Department of Medicine, Nnamdi Azikiwe University Teaching Hospital, PMB 5025, Anambra State, Nnewi 435101, Nigeria
2Department of Medicine, University of Nigeria Teaching Hospital, PMB 01129, Enugu State, Enugu 400001, Nigeria
3Department of Chemical Pathology, Nnamdi Azikiwe Teaching Hospital, PMB 5025, Anambra State, Nnewi 435101, Nigeria

Received 1 September 2012; Accepted 3 October 2012

Academic Editors: W. S. Aronow and D. Franco

Copyright © 2012 E. I. Onwubuya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “Coronary artery disease,” in Non-Commucable Disease in Nigeria, O. O. Akinkugbe, Ed., vol. 2 of 1, pp. 13–22, 1992.
  2. J. M. Gaziano, H. D. Sesso, J. L. Breslow, C. H. Hennekens, and J. E. Buring, “Relation between systemic hypertension and blood lipids on the risk of myocardial infarction,” American Journal of Cardiology, vol. 84, no. 7, pp. 768–773, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Hachinski, C. Graffagnino, M. Beaudry et al., “Lipids and stroke: a paradox resolved,” Archives of Neurology, vol. 53, no. 4, pp. 303–308, 1996. View at Google Scholar · View at Scopus
  4. B. C. Hansen, “The metabolic syndrome X,” Annals of the New York Academy of Sciences, vol. 892, pp. 1–24, 1999. View at Google Scholar · View at Scopus
  5. M. J. Landray, E. Edmunds, F. L. Li-Saw-Hee et al., “Abnormal low-density lipoprotein subfraction profile in patients with untreated hypertension,” The Quarterly Journal of Medicine, vol. 95, no. 3, pp. 165–171, 2002. View at Google Scholar · View at Scopus
  6. M. J. Landray, G. Sagar, J. Muskin, S. Murray, R. L. Holder, and G. Y. H. Lip, “Association of atherogenic low-density lipoprotein subfractions with carotid atherosclerosis,” The Quarterly Journal of Medicine, vol. 91, no. 5, pp. 345–351, 1998. View at Google Scholar · View at Scopus
  7. A. Gnasso, M. C. Calindro, C. Carallo et al., “Awareness, treatment and control of hyperlipidaemia, hypertension and diabetes mellitus in a selected population of southern Italy,” European Journal of Epidemiology, vol. 13, no. 4, pp. 421–428, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Edmunds, M. J. Landray, F. L. Li-Saw-Hee, B. A. Hughes, D. G. Beevers, and G. Y. H. Lip, “Dyslipidaemia in patients with malignant-phase hypertension,” The Quarterly Journal of Medicine, vol. 94, no. 6, pp. 327–332, 2001. View at Google Scholar · View at Scopus
  9. J. E. Ahaneku, G. O. Taylor, E. O. Agbedana, O. Walker, and L. A. Salako, “Changes in lipid and lipoprotein values during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients,” Journal of the Pakistan Medical Association, vol. 444, no. 7, pp. 166–169, 1994. View at Google Scholar · View at Scopus
  10. A. O. Falase, L. A. Salako, and A. F. Aderounmu, “Beta-adrenergic receptor blockers in the of hypertension: a trial of pindolol in Africans,” Cardiologic Tropicale, vol. 11, pp. 111–120, 1972. View at Google Scholar
  11. J. E. Ahaneku, M. C. Nwosu, G. I. Ahaneku, and P. C. Okugba, “Underutilization of lipid profile investigations in disease management in Nigeria,” East African Medical Journal, vol. 76, no. 3, pp. 46–49, 1999. View at Google Scholar · View at Scopus
  12. C. Borghi, A. Dormi, M. Veronesi, Z. Sangiorgi, and A. Gaddi, “Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study,” American Heart Journal, vol. 148, no. 2, pp. 285–292, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. World Health Organization, “International Society of Hypertension: guideline for management of hypertension. Guideline subcommittee,” Journal of Hypertension, vol. 17, pp. 151–183, 1999. View at Google Scholar
  14. S. K. Lwanga and E. Tye, Teaching Health Statistics. Twenty Lessons and Seminars, vol. 70, World Health Organization, Geneva, Switzerland, 1986.
  15. The Guideline Sub-Committee for the WHO-ISH Mild Hypertension Laison Committee, “Guidelines for the management of mild hypertension. Mild hypertension memorandum for a World Health Organisation—international society of hypertension meeting,” Journal of Hypertension, vol. 11, pp. 905–918, 1993. View at Google Scholar
  16. J. I. Cleeman, “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Google Scholar · View at Scopus
  17. M. Mackness and P. N. Durrington, “Lipopritein separation and analysis for clinical studies,” in Lipoprotein Analysis. Practical Approach, C. A. Converse and E. R. Skinner, Eds., pp. 1–42, Oxford University Press, New York, NY, USA, 1st edition, 1992. View at Google Scholar
  18. G. R. Warinck, Methods in Enzymology, vol. 129, Academic Press, London, UK, 1986.
  19. H. K. Naito and J. A. David, Lipid Research Methodology, vol. 1, Alan R. Liss, New York, NY, USA, 1984.
  20. W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge,” Clinical Chemistry, vol. 18, no. 6, pp. 499–502, 1972. View at Google Scholar · View at Scopus
  21. O. Aduba, I. Onwuamaeze, J. Oli, and K. Udeozo, “Serum cholesterol and high density lipoprotein cholesterol in Nigerian diabetics,” East African Medical Journal, vol. 61, no. 1, pp. 35–39, 1984. View at Google Scholar · View at Scopus
  22. G. O. Taylor, “Studies of serum lipids in Nigeria,” Tropical and Geographical Medicine Journal, vol. 23, pp. 158–166, 1971. View at Google Scholar
  23. G. O. Taylor and E. O. Agbedana, “A comparative study of plasma high-density lipoprotein cholesterol in two groups of Nigerians of different socio-economic status,” African Journal of Medicine and Medical Sciences, vol. 12, no. 1, pp. 23–28, 1983. View at Google Scholar · View at Scopus
  24. Y. K. Seedat and F. G. H. Mayet, “Risk factors leading to coronary heart disease among the Black, Indian and White peoples of Durban,” Journal of Human Hypertension, vol. 10, supplement 3, pp. S93–S94, 1996. View at Google Scholar · View at Scopus
  25. I. Hjermann, “The metabolic cardiovascular syndrome: syndrome X, reaven's syndrome, insulin resistance syndrome, atherothrombogenic syndrome,” Journal of Cardiovascular Pharmacology, vol. 20, supplement 8, pp. S5–S10, 1992. View at Google Scholar · View at Scopus
  26. C. Bruce, R. A. Chouinard Jr., and A. R. Tall, “Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport,” Annual Review of Nutrition, vol. 18, pp. 297–330, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. S. M. Grundy, “Age as a risk factor: you are as old as your arteries,” American Journal of Cardiology, vol. 83, no. 10, pp. 1455–1457, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. R. M. J. Palmer, A. G. Ferrige, and S. Moncada, “Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor,” Nature, vol. 327, no. 6122, pp. 524–526, 1987. View at Google Scholar · View at Scopus